Novo Nordisk now has a 30.3 percent share of the diabetes market, and is well on the way to achieving its long-term goal of controlling a third of the market. In 2019, the company’s market share was 28 percent.
Executive Vice President for Commercial Strategy and Corporate Affairs Camilla Sylvest mentioned this goal at Novo’s capital markets day, saying that over the next few years, growth is expected to be driven by GLP-1 products like tablet Rybelsus and the company’s best-selling drug Ozempic.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
US to start using Bavarian vaccine stockpile
In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
CHMP to remove 100 generic medicines from market
Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.
Germany orders 40,000 monkeypox vaccines from Bavarian Nordic
The German Minister for Health has revealed that the German state has ordered vaccines from Bavarian Nordic, as the country reports 5 cases of monkeypox.
Account Manager 
Innovation Project Manager, Display Unit 
Director of Toxicology 
Senior Manager, Clinical Trial Budget 
Scientific Writer 
SAP System Specialist (Product Supply) – Business Application Services 
Communications Consultant 
Director Global Engineering 
Clinical Trial Manager for development of in vitro diagnostics 
Nordic Medical Affairs Manager 
Senior Project Manager (GMP - Life Science) 
System Sales Development Consultant - Investment Projects, Merck Millipore 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Client Talent Acquisition Specialist 
Clinical Project Manager 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Biomarker Operations Lead 
(Senior) Drug Substance Specialist